Sit Investment Associates’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$100K Buy
+3,060
New +$110K ﹤0.01% 475
2016
Q3
Sell
-23,125
Closed -$1.1M 451
2016
Q2
$1.1M Buy
+23,125
New +$979K 0.03% 303

Other funds holding CNMD

Sit Investment Associates's CNMD Position: Q2 2026 in Review

Sit Investment Associates opened a new position in CONMED (CNMD) in Q2 2026: 3,060 shares worth $100K. The stake represents ﹤0.01% of the portfolio and ranks #475 among its holdings. This is a return to the name: Sit Investment Associates previously reported a position in CNMD as recently as Q2 2016.

Sit Investment Associates first reported a position in CNMD in Q2 2016 and has held it in 2 quarters since. The position peaked at $1.1M in Q2 2016. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Sit Investment Associates held 3,060 shares of CONMED worth $100K as of Q2 2026.
  • CONMED was a new Sit Investment Associates position in Q2 2026.
  • CONMED made up ﹤0.01% of Sit Investment Associates's portfolio in Q2 2026, its #475 holding.
  • Sit Investment Associates first reported a position in CONMED in Q2 2016 and has held it in 2 quarters since.
  • Sit Investment Associates's CONMED position peaked at $1.1M in Q2 2016.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Sit Investment Associates's 13F filing for Q2 2026, filed 12 Aug 2026.